IntelGenx Technologies Corp.
IGX
Rangering i aksjer
#28065
IntelGenx Technologies Corp. is a pharmaceutical drug delivery enterprise... IntelGenx Technologies Corp. is a pharmaceutical drug delivery enterprise focused on the creation and manufacturing of advanced oral thin film products. The company's diverse product pipeline encompasses various oral film formulations designed to address a wide spectrum of medical conditions. These include INT0008/2008, a Rizatriptan film for migraine management; INT0046/2018 for adult applications; INT0007/2006, an oral film targeting erectile dysfunction; INT0043/2015, a montelukast-based film for Alzheimer's disease; INT0027/2011, intended for opioid addiction treatment; INT0010/2006, addressing neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, formulated for schizophrenia or bipolar I disorder; and INT0048/2020, developed for veterinary health. Additionally, IntelGenx is actively developing other candidates identified as INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has established strategic partnerships, including a comprehensive licensing, development, and supply agreement with Tilray, Inc., alongside a development pact with Cynapsus Therapeutics Inc. Founded in 2003, IntelGenx Technologies Corp. is headquartered in Montreal, Canada.
Aksjekurs
$0.17446996
Sist synkronisert: 2024-06-11
Markedsverdi
$26.97M
Endring (1 dag)
-0.57%
Endring (1 år)
2.63%
Land
CA
Handel IntelGenx Technologies Corp. (IGX)
Kategori
Healthcare
Aksjeprishistorikk for IntelGenx Technologies Corp. (IGX)
Høyeste sluttskurs: $0.17 den 2025-05-01
Laveste sluttskurs: $0.71 den 2007-01-01
Laveste sluttskurs: $0.71 den 2007-01-01
Aksjeprishistorikk for IntelGenx Technologies Corp. fra 2007 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2025 | 0.00% |
| 2024 | 25.41% |
| 2023 | -7.05% |
| 2022 | -63.89% |
| 2021 | 65.40% |
| 2020 | -50.36% |
| 2019 | -8.97% |
| 2018 | -25.87% |
| 2017 | -2.69% |
| 2016 | 47.56% |
| 2015 | -7.76% |
| 2014 | 6.34% |
| 2013 | -14.80% |
| 2012 | 26.81% |
| 2011 | 48.44% |
| 2010 | -44.05% |
| 2009 | 73.36% |
| 2008 | -50.74% |
| 2007 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $527.18 | 23.67% |
US
|
|
| $251.29 | 814.11% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $890.85 | 6.72% |
NL
|
|
| $752.87 | 7.40% |
CH
|
